共查询到19条相似文献，搜索用时 796 毫秒
1.
旨在探讨影响马胚胎移植效率的几种关键因素。本研究统计了国内北京马场、河北马场和山东马场2013-2018年胚胎移植数据,3个马场供体马数量分别为15、21和25匹,受体母马数量分别为56、50和75匹。所有母马年龄为3~12岁。统计供体马冲胚时间对胚胎回收率的影响;胚胎日龄对移植后受体马妊娠率的影响;供、受体母马排卵同期化程度对移植后妊娠率的影响;受体母马居住移植基地时间对移植后妊娠率的影响。结果显示,母马在配种季节注射前列腺素（PG）+GnRH类似物或PG+hCG诱发排卵,发情周期分别为（14.5±0.8）和（14.3±1.1）d,显著低于对照组的（（20.5±2.6）d,P<0.05）;排卵后第8天冲洗子宫的胚胎回收率均高于第7天,但差异不显著;8日龄胚胎移植后受体马的妊娠率均高于7日龄,差异不显著;供体母马排卵比受体母马早1 d时,胚胎移植后的妊娠率最高;受体母马在移植基地居住时间大于1年时,移植后妊娠率高于居住时间小于0.5年的受体马。根据以上结果,本研究得出如下结论,PG与hCG或GnRH类似物联合使用可缩短母马发情周期,母马排卵后第8天的胚胎回收率和移植后妊娠率较高,胚胎移植时选择居住时间大于1年且排卵时间比供体晚1 d的母马作受体。 相似文献
2.
《畜牧兽医学报》2020,(1)
旨在探讨影响马胚胎移植效率的几种关键因素。本研究统计了国内北京马场、河北马场和山东马场2013-2018年胚胎移植数据,3个马场供体马数量分别为15、21和25匹,受体母马数量分别为56、50和75匹。所有母马年龄为3～12岁。统计供体马冲胚时间对胚胎回收率的影响;胚胎日龄对移植后受体马妊娠率的影响;供、受体母马排卵同期化程度对移植后妊娠率的影响;受体母马居住移植基地时间对移植后妊娠率的影响。结果显示,母马在配种季节注射前列腺素(PG)+GnRH类似物或PG+hCG诱发排卵,发情周期分别为(14.5±0.8)和(14.3±1.1)d,显著低于对照组的((20.5±2.6)d,P0.05);排卵后第8天冲洗子宫的胚胎回收率均高于第7天,但差异不显著;8日龄胚胎移植后受体马的妊娠率均高于7日龄,差异不显著;供体母马排卵比受体母马早1d时,胚胎移植后的妊娠率最高;受体母马在移植基地居住时间大于1年时,移植后妊娠率高于居住时间小于0.5年的受体马。根据以上结果,本研究得出如下结论,PG与hCG或GnRH类似物联合使用可缩短母马发情周期,母马排卵后第8天的胚胎回收率和移植后妊娠率较高,胚胎移植时选择居住时间大于1年且排卵时间比供体晚1d的母马作受体。 相似文献
3.
为研究妊娠早期子宫内交感神经对PCNA的调控效应,选取180~200日龄健康的性成熟Wistar雌性大鼠36只,随机分为对照组和处理组,处理组采用静脉注射6-OHDA损毁交感神经。采用免疫组化法和qRT-PCR法,观察和分析交感神经对妊娠早期大鼠子宫内膜组织学结构以及PCNA分布的影响。结果表明,PCNA阳性物质主要分布在固有层浅层的蜕膜细胞及肌层的外纵肌细胞核内存在。损毁交感神经后,子宫腺较正常的妊娠状态减少,腺上皮变薄,PCNA免疫阳性细胞减少,子宫内膜的蜕膜细胞及平滑肌细胞等的PCNA发生异常表达,特别是着床前的妊娠第4天(处理组)大鼠子宫腺数量减少,但腺上皮内PCNA免疫阳性细胞增强,子宫正常的组织学微环境被打乱,导致囊胚不能与子宫建立联系,出现着床数下降而排卵数基本正常的状况。免疫组化观察和mRNA相对表达量的统计分析均显示损毁支配子宫的交感神经后,导致子宫组织的蜕膜细胞及平滑肌细胞等的PCNA发生异常表达,打破了正常生理状态下子宫内膜发育与胚泡发育的同步性,影响妊娠早期的胚泡着床。 相似文献
4.
为了研究交感神经对小鼠妊娠早期(妊娠第1～9天)子宫内膜发育的影响,本试验采用交感神经阻断剂6-羟多巴胺(6-OHDA,100 mg·kg~(-1)体质量)腹腔注射成年雌性昆明小白鼠,损毁外周交感神经.利用放射免疫分析法、组织学和免疫组织化学技术,检测了小鼠妊娠早期血清17β-雌二醇水平、子宫腺发育和子宫内膜细胞增殖的变化.结果显示:(1)在妊娠第1天(E1)、E5和E7 6-OHDA处理组血清中17β-雌二醇的含量分别降低了63.4%(P<0.01)、35.7%(P<0.05)和25.5%(P<0.05),而在E3和E9分别升高了79.3%(P<0.05)和156.7%(P<0.01);(2)6-OHDA处理降低了妊娠早期子宫腺的比例,与同期对照组相比分别下降了37.5%、38.6%、41.8%、61.4%和58.1%(P<0.01);(3)6-OHDA处理降低了妊娠早期子宫内膜细胞的增殖,使E1、E3、E5、E7和E9子宫内膜增殖细胞分别减少了27.2%、30.2%、40.7%、27.2%和27.7%(P<0.01).上述结果表明,交感神经对雌激素的分泌以及妊娠早期子宫组织结构的重建具有重要的调控作用,进而调节动物早期胚胎的着床和发育. 相似文献
5.
交感神经阻断小鼠妊娠早期子宫内肥大细胞的分布 总被引：2，自引：0，他引：2
为了研究交感神经对哺乳动物早期胚胎发育的影响机制,通过腹腔注射6-羟多巴胺使交感神经阻断后,观察了小鼠妊娠前期胚胎早期发育和肥大细胞数量和型别的变化。结果显示,交感神经阻断后,不仅对胚胎早期发育有影响,使胚胎着床数降低64.4%,而且影响子宫内肥大细胞的数量及其型别分布。妊娠4d(E4)时肥大细胞数量明显升高(P<0.01),同时肥大细胞分型也有所变化,即黏膜型肥大细胞主要存在于胚胎着床前和着床后,结缔组织型肥大细胞没有明显差异,混合型肥大细胞主要存在于着床期间。这一结果表明,妊娠早期子宫肥大细胞数量与型别的变化可能是交感神经影响早期胚胎发育的途径之一。 相似文献
6.
早期研究表明:经产母牛输精期卵泡大小显著影响其受胎率和授精后胚胎/胎儿死亡率,但对自然排卵的母牛受胎率没有影响。本研究目标是分析青年母年受胎率、胚胎/胎儿死亡率同排卵前期卵泡大小、诱导或自发排卵后血液循环中雌二醇浓度之间的关系。青年母牛分为成2组不同的繁殖牛群进行人工授精:①利用同期发情和诱导排卵后授精(TAI,n=98);②在23 d发情周期中,利用电子检测仪检测母牛发情后12 h授精(自然排卵,n=110)。利用直肠超声波检查输精时卵泡大小和输精后27、41、55和68d怀孕状态。测定的青年母牛中仅有6头出现后期胚胎或早期胎儿死亡。繁殖牛群和卵泡大小的相互作用并不影响母牛受胎率。结合繁殖牛群数据分析,卵泡大小对受胎率的对数回归特征表现为曲线(P<0.01),并且预测出卵泡大小为12.8mm时,受胎率最高(为68.0±4.9%)。卵泡直径小于10.7 mm或大于15.7 mm时,受胎率都较直径为12.8 mm卵泡低。直径小于10.7 mm卵泡(有28%的青年母牛妊娠)则比大于15.7 mm的卵泡(仅有4%)更易受孕。授精后24 h内有发情行为的青年母牛所排卵泡直径(12.2±0.2 mm)、雌二醇浓度(9.9±0.6)以及妊娠率(63%)都显著高于无发情行为的母牛(分别为11.1±0.3mm,6.6±0.7,20%)(P<0.01)。然而,对卵泡大小差异进行分析后,发现妊娠率又与发情行为表现和雌二醇浓度无关。因此,血清雌二醇浓度和发情行为对妊娠的影响似乎通过卵泡大小来介导的,并且优化卵泡大小的管理实践可以提高受胎率。 相似文献
7.
超数排卵(超排)的目的是获得最大数量的可移植胚胎,在传统的超排方案中,处理于发情周期的中期(排卵后8￣12天,等于发情后9￣13天),奶牛在超排前,需要通过直肠检查卵巢黄体的质量好坏才能确定是否选用。其一是增加了劳动强度;其二是一部分牛因排卵后没能形成好的黄体而未被利用,而且超排处理一般在产后60天进行,重复超排间隔时间延长到2个月、甚至半年以上,严重影响了高产奶牛的利用率,减少了可移植胚胎的数量。目前,我们采用通过控制卵泡波同期化方法,在奶牛发情后的任意1天,在不做发情检测的情况下,在供体牛阴道内放置CIDR(孕酮阴道硅胶… 相似文献
8.
《中国兽医学报》2017,(7):1300-1308
为研究交感神经对妊娠早期子宫内DKK-1和Wnt-1的调控作用,选取180~200日龄健康的性成熟Wistar雌性大鼠,随机分为对照组和处理组,处理组采用静脉注射6-OHDA损毁交感神经,用免疫组化法和qRT-PCR法,观察和分析交感神经对妊娠早期大鼠子宫内膜的DKK-1和Wnt-1蛋白及mRNA相对表达量的影响。结果显示:6-OHDA损毁交感神经后,对卵巢排卵数无显著性影响,但子宫囊胚数量显著下降、囊胚发育延迟,导致子宫腔上皮和腺上皮细胞自分泌DKK-1和Wnt-1紊乱,呈现与正常状态相反的变化趋势。结果表明:在着床窗口期,交感神经通过影响DKK-1对Wnt-1信号分子的调控作用而影响囊胚着床、发育。 相似文献
9.
10.
为了研究发情旺季母水牛生殖激素水平的变化规律,试验采用酶联免疫分析方法(ELISA)测定了发情周期血样中的促卵泡素(FSH)、促黄体素(LH)、雌二醇(E2)和孕酮(P4)4种激素,并分析了这些生殖激素在发情周期中的变化规律。结果表明:血清中FSH和LH的含量均由排卵前的第4天开始缓慢上升,排卵前达到峰值,在排卵后又明显下降;E2的含量在排卵前1天出现峰值,在排卵后第9天又出现1个小波峰;P4的含量在排卵后的第5天明显上升,第13天时达峰值,在排卵前3天出现最低水平。 相似文献
11.
Dynamics of ovarian follicular development in cattle during the estrous cycle, early pregnancy and in response to PMSG 总被引：1，自引：0，他引：1
Ovarian follicular dynamics of cattle were examined during the estrous cycle, early pregnancy and in response to PMSG. Number and size of follicles were monitored by ultrasonographic examinations. During the estrous cycle, distinct periods of follicular dominance (measured by the increase in difference in size between the largest and second largest follicle) occurred in both the luteal (Days 6-8) and proestrus (18-22) phases of the estrous cycle (two follicular waves). Associated with the well timed development of the first dominant follicle was a change in distribution of follicle numbers in small (less than 5 mm; increased on Days 2-4), medium (6-8 mm; increased on Days 3-5) and large (greater than or equal to 9 mm; increased on Days 6-9) follicular size classes. Follicular development was greater on the ovary bearing the CL for the period that the CL was present. The dominant follicle formed during the first follicular wave was capable of ovulating (6 of 8 heifers) following an injection of a synthetic analogue of prostaglandin F-2 alpha on Day 9 of the estrous cycle. During early pregnancy (Days 6-34), follicular development (size of largest follicle, number of follicles and total accumulated size of all follicles) on the ovary bearing the CL was suppressed between Days 24 and 34 of pregnancy. This was a local effect in that follicular development was sustained on the contralateral ovary. Therefore, the CL or conceptus may be regulating follicular development in a manner to help prevent luteolysis. Associated with the injection of PMSG was an initial increase in the number of small follicles followed by their recruitment into medium and large size classes leading to ovulation. Number of follicles greater than 5 mm on the Day of estrus was related (r = .97) to the number of subsequent embryos and oocytes collected. Ultrasonography is a valuable technique to monitor ovarian follicular dynamics in cattle, and can thereby be used to infer changes in physiological and endocrine states. 相似文献
12.
为了研究交感神经对小鼠胚胎着床和发育的作用机制,本文筛选出合适的L-苯丙氨酸浓度(320 mg/kg体重),处理孕鼠,观察胚胎着床和发育,通过甲苯胺蓝染色检测子宫局部肥大细胞的变化.研究结果显示,320 mg/kg体重L-苯丙氨酸能显著降低胚胎着床数目,分别下降了45％ (E7)和58％(E9),并且显著延缓胚胎的发育；与对照组相比,着床后子宫局部肥大细胞数目显著降低,分别在E5～E9降低了36.62％、64.59％和23.30％,差异显著.由本研究结果可以推断一定浓度的L-苯丙氨酸可以激活交感神经,影响妊娠早期子宫局部肥大细胞数量,从而改变子宫局部微环境,影响胚胎着床和发育. 相似文献
13.
Fifty crossbred gilts immunized against bovine serum albumin (BSA) or androstenedione conjugated to BSA (AD) were used in three experiments. Primary immunizations were given at 120 d of age and boosters at 148 and 176 d. Gilts were moved to pens containing four to five animals each and exposed to boars beginning at 180 d of age. Immunization against AD did not affect age at puberty, percentage of gilts exhibiting estrus or duration of first estrous cycle. Over the three experiments, ovulation rate was 24% greater for AD-immunized gilts than for controls, and the number of corpora lutea was related positively (r = .82) to the log of the antibody titer. Number of ovulations decreased as interval from booster immunization to onset of estrus increased. During diestrus of the first estrous cycle, gilts immunized against AD had more follicles 5 to 10 mm in diameter, more total ovarian follicles and more total ovarian structures (corpora lutea plus follicles) than controls. Immunization against AD increased the frequency of LH pulses on d 16 but not on d 17 or 18, of the estrous cycle. However, average serum concentrations of LH, FSH and estradiol from 5 d before until 2 d after expected estrus were not different between treatment groups. Concentrations of AD in follicles 4 to 6 and greater than 7 mm in diameter were greater in gilts immunized against AD. Mean serum progesterone was higher on d 9 and 12 after mating in AD immunized gilts than in controls. Immunization against AD had no effect on maintenance of pregnancy or embryo survival rate. 相似文献
14.
Cochran RA Leonardi-Cattolica AA Sullivan MR Kincaid LA Leise BS Thompson DL Godke RA 《Domestic animal endocrinology》1999,16(1):57-67
The effects of exogenous equine somatotropin (eST) administration on ovarian activity and plasma hormone levels were evaluated on horse and pony mares. The objectives of this study were to determine the effects of eST on follicular development and circulating concentrations of leutinizing hormone (LH), estradiol, progesterone, and insulin-like growth factor I (IGF-I) in cyclic horse and pony mares. Sixteen mares received daily injections (i.m.) of eST at a concentration of 25 micrograms/kg body weight on either Days 6 through 12 (Treatment A) or 13 through 19 (Treatment B) postovulation. In addition, contemporary mares were similarly given the carrier vehicle and served as controls (Treatments C and D). Blood samples were collected at 24-hr intervals and ultrasonographic evaluations were performed on the ovaries of each mare at 48-hr intervals beginning on the first day of treatment and ending either on the day of ovulation or 5 d postovulation. Circulating levels of insulin-like growth factor-I (IGF-I) were increased in treated mares by Day 3 post-treatment (P < 0.05). Also, mares in Treatment B exhibited a decrease in plasma estradiol concentrations (P < 0.05) when compared with control mares on Days 1 through 5 postovulation of the post-treated estrous cycle. In addition, circulating leutinizing hormone levels were different for mares in Treatment A compared with controls on Days--8 through--1 pre-ovulation (P < 0.05). All follicles present on the ovaries of each mare were measured and placed into one of five categories based on their diameter. Neither the mean number of follicles per size category > or = 8 mm in diameter nor the mean follicular diameter within each size category differed among treatment and control mares. However, eST treatment significantly increased the number of follicles < or = 7 mm on the ovaries of mares treated early in the estrous cycle when compared with control mares on Days 3 and 7 post-treatment and at the onset of standing estrus. 相似文献
15.
Adult Suffolk ewes (n = 14) were treated on d 10 of the estrous cycle with anti-bovine luteinizing hormone (LH) antiserum. Control ewes (n = 10) were treated with normal horse serum. Estrous behavior and the number of corpora lutea and ovarian follicles were examined at the subsequent estrous cycle. Daily plasma concentrations of progesterone (P4), follicle stimulating hormone (FSH) and estradiol were determined before and after treatment. Ewes treated with antiserum had a higher (P less than .05) ovulation rate (2.7 +/- .2) than did controls (2.1 +/- .1). No differences were found in the numbers of large (greater than 5 mm) or small (less than 5 mm) follicles between treatment groups. Estrus was delayed (P less than .025) approximately .6 d/in ewes treated with antisera. Immunoreactive FSH increased (P less than .05) within 1 d after treatment and remained higher than the controls for 5 d. Peak estradiol concentrations occurred on d 17 for treated ewes compared with peak concentrations on d 15 or 16 for control ewes. The P4 concentrations were generally less (P less than .025) in treated ewes throughout the luteal phase of the treatment cycle. These data demonstrate that ovulation rate is increased in ewes treated with LH antiserum. The marked increase in plasma FSH suggests a possible mechanism whereby ovulation rate is enhanced. 相似文献
16.
In this study the use of hCG for induction of ovulation is described. Factors such as follicle diameter at the time of administration of hCG (3000 IE hCG i.v.), follicular growth after hCG and the rate of double ovulations were evaluated. A total of 168 mares presented for artificial insemination were used. In 249 estrous periods hCG was given to mares exhibiting standing estrous when a minimum follicle diameter of 30 mm and a well developed edema of the endometrium could be detected by ultrasonography. In nine estrous periods ovulation occurred within 24 hours after hCG. The majority of mares (216; 86.7%) ovulated 24 to 48 hours after hCG and in 24 cases ovulation was delayed beyond 48 hours. Follicle size at the time of hCG administration (30-34 mm, 35-39 mm, > or = 40 mm) had no influence on the percentage of mares ovulating 24 to 48 hours after hCG (89.2%, 87.9%, and 83.7%, respectively). Double ovulations could be observed in 17.7% of estrous periods. The one cycle pregnancy rate was not influenced by follicle size (small 45.9%; medium 41.6%; large 47.5%). Repeated treatments with hCG during successive estrous cycles within one year did not influence the rate of responding to hCG. Mares in standing estrous respond well to hCG if a minimum follicle size of 30 mm and a well developed endometrial folding is present. 相似文献
17.
《Journal of Equine Veterinary Science》2000,20(7):450-453
A recent report suggested administration of altrenogest during the follicular phase could postpone ovulation. Based on these results, two questions were generated. We first hypothesized that by initiating a altrenogest treatment earlier in the estrous cycle, a greater and/or more consistent delay in ovulation would result. Second, we hypothesized that exposure to elevated progestin concentrations might alter viability of the ovulatory follicle and oocyte. The focus of the first experiment was to determine if initiation of altrenogest treatment at different stages of the estrous cycle would yield a more predictable time to ovulation, whereas the second experiment was designed to determine whether mares receiving altrenogest during estrus had compromised fertility. In the first experiment thirty mares of mixed light breed, ranging in age from 5-15 years, were randomly assigned to one of three groups. The two treated groups received altrenogest (0.088 mg/kg of body weight) for two days once a follicle of 30 or 35 mm in diameter was detected. Control mares were not treated. Mares treated with altrenogest whether initiated at the detection of a 30 or 35 mm follicle demonstrated similar (P>.05) day to ovulation interval when adjusted to 35 mm (5.4 and 5.6 days, respectively). Both treated groups demonstrated a delayed interval (P<.05) when compared to control (3.9 days). Thirty-six mares of similar breed and age, were randomly assigned to two groups for use in the second experiment. All mares were monitored daily via transrectal ultrasonography from the time a 35 mm or greater follicle was detected until ovulation. Treated mares received daily doses of altrenogest (0.088 mg/kg of body weight) for two days once a follicle of 35 mm or greater was detected. Control mares received no treatment. Fertility data were collected from mares inseminated every other day with 500 million motile spermatozoa from one of two stallions with proven fertility. Pregnancy data were collected via transrectal ultrasonography at days 12, 14 and 16 post-ovulation. Ovulation data were collected from 27 control cycles and 26 treated cycles. Contrary to previous reports and Experiment 1, no difference (P=0.35) was noted between groups with respect to days to ovulation. Control mares averaged 4.14 days and treated mares averaged 4.7 days to ovulation from initial detection of a 35 mm follicle. Fertility data were also similar (P=0.8) between control and treated mares (66.6% and 61.5% per cycle, respectively). Interestingly, a greater number (P=0.017) of treated cycles (5/26) resulted in follicular regression than did control cycles (0/27). While these data suggest that this dosage of altrenogest may not postpone ovulation, it did appear related to increased incidence of follicular regression. Fertility was unaffected, however, in those mares that ovulated. Further studies are needed in which initiation at different stages of estrus and different doses of altrenogest are used. 相似文献
18.
A Nakajima S Hiraizumi K Onodera H Suzuki Y Kudo I Domeki 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》1992,54(1):95-98
Thirteen beef cows were superovulated using 4,000 i.u. of pregnant mare serum gonadotrophin (PMSG) on days 9 to 14 of the estrous cycle, followed by two injections of 500 micrograms prostaglandin F2 alpha analogue (PGF2 alpha) 48 and 55 hrs later. Seven of them were injected intramuscularly with bovine anti-PMSG serum 12 hrs after the first signs of estrus. The remaining 6 cows were served as controls and received no antiserum. Peripheral blood concentrations of progesterone (P) and estradiol-17 beta (E2) were compared in relation to the superovulatory responses. The injection of anti-PMSG serum did not significantly affect the numbers of the corpora lutea (CL), the anovulatory follicles and the transferable embryos at 7 to 8 days after superovulatory estrus, but increased the ratio of embryos classified as excellent or good quality. Although the plasma P concentration showed no significant differences between the anti-PMSG-treated and control cows, the plasma E2 concentration displayed a characteristic difference, suppressing the second E2 peak in the anti-PMSG-treated cows. It is concluded that the use of bovine anti-PMSG serum for PMSG/PGF2 alpha-treated cows at 12 hrs after the beginning of the estrus improves the quality of embryos recovered, probably due to inhibition of high estrogenic environment following ovulation. 相似文献
19.
Farquhar VJ McCue PM Nett TM Squires EL 《Journal of the American Veterinary Medical Association》2001,218(5):749-752
OBJECTIVE: To evaluate gonadotropin secretion and ovarian function after administration of deslorelin acetate to induce ovulation in mares. DESIGN: Randomized controlled trial. ANIMALS: 16 healthy mares with normal estrous cycles. PROCEDURE: 8 control mares were allowed to ovulate spontaneously, whereas 8 study mares received deslorelin to induce ovulation when an ovarian follicle > 35 mm in diameter was detected. Follicle development and serum concentrations of gonadotropins were monitored daily during 1 estrous cycle. Pituitary responsiveness to administration of gonadotropin-releasing hormone (GnRH) was evaluated 10 days after initial ovulation. RESULTS: Interovulatory intervals of mares treated with deslorelin (mean +/- SD, 25.6 +/- 2.6 days) were longer than those of control mares (22.9 +/- 1.8 days). Diameter of the largest follicle was significantly smaller during 2 days of the diestrous period after ovulation in deslorelin-treated mares than in control mares. Concentrations of follicle-stimulating hormone (FSH) were lower in deslorelin-treated mares on days 5 through 14 than in control mares. Concentrations of luteinizing hormone were not different between groups during most of the cycle. Gonadotropin release in response to administration of GnRH was lower in mares treated with deslorelin acetate than in control mares. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of deslorelin was associated with reduction in circulating concentrations of FSH and gonadotropin response to administration of GnRH during the estrous cycle. Low concentration of FSH in treated mares may lead to delayed follicular development and an increased interovulatory interval. 相似文献